144 related articles for article (PubMed ID: 7832304)
1. Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450.
Oda Y; Furuichi K; Tanaka K; Hiroi T; Imaoka S; Asada A; Fujimori M; Funae Y
Anesthesiology; 1995 Jan; 82(1):214-20. PubMed ID: 7832304
[TBL] [Abstract][Full Text] [Related]
2. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
Ekström G; Gunnarsson UB
Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604
[TBL] [Abstract][Full Text] [Related]
3. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
4. Effect of propofol on ropivacaine metabolism in human liver microsomes.
Osaka Y; Inomata S; Tanaka E; Nakamura T; Honda K; Miyabe M; Toyooka H; Tanaka M
J Anesth; 2006; 20(1):60-3. PubMed ID: 16421682
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes.
Mimura M; Yamazaki H; Sugahara C; Hiroi T; Funae Y; Shimada T
Biochem Pharmacol; 1994 Jun; 47(11):1957-63. PubMed ID: 7912070
[TBL] [Abstract][Full Text] [Related]
6. Effects of premedication medicines on the formation of the CYP3A4-dependent metabolite of ropivacaine, 2', 6'-Pipecoloxylidide, on human liver microsomes in vitro.
Tanaka E; Nakamura T; Inomata S; Honda K
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):181-3. PubMed ID: 16445592
[TBL] [Abstract][Full Text] [Related]
7. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes.
Oda Y; Imaoka S; Nakahira Y; Asada A; Fujimori M; Fujita S; Funae Y
Biochem Pharmacol; 1989 Dec; 38(24):4439-44. PubMed ID: 2604746
[TBL] [Abstract][Full Text] [Related]
9. Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine.
Berggren S; Lennernäs P; Ekelund M; Weström B; Hoogstraate J; Lennernäs H
J Pharm Pharmacol; 2003 Jul; 55(7):963-72. PubMed ID: 12906753
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
11. Identification of cytochrome P450 enzymes involved in the metabolism of zotepine, an antipsychotic drug, in human liver microsomes.
Shiraga T; Kaneko H; Iwasaki K; Tozuka Z; Suzuki A; Hata T
Xenobiotica; 1999 Mar; 29(3):217-29. PubMed ID: 10219963
[TBL] [Abstract][Full Text] [Related]
12. Effect of ciprofloxacin on the pharmacokinetics of ropivacaine.
Jokinen MJ; Olkkola KT; Ahonen J; Neuvonen PJ
Eur J Clin Pharmacol; 2003 Feb; 58(10):653-7. PubMed ID: 12610740
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on nobiletin metabolism with liver microsomes from rats, Guinea pigs and hamsters and rat cytochrome p450.
Koga N; Matsuo M; Ohta C; Haraguchi K; Matsuoka M; Kato Y; Ishii T; Yano M; Ohta H
Biol Pharm Bull; 2007 Dec; 30(12):2317-23. PubMed ID: 18057719
[TBL] [Abstract][Full Text] [Related]
14. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
15. Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A.
Gantenbein M; Attolini L; Bruguerolle B; Villard PH; Puyoou F; Durand A; Lacarelle B; Hardwigsen J; Le-Treut YP
Drug Metab Dispos; 2000 Apr; 28(4):383-5. PubMed ID: 10725304
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors.
Arlander E; Ekström G; Alm C; Carrillo JA; Bielenstein M; Böttiger Y; Bertilsson L; Gustafsson LL
Clin Pharmacol Ther; 1998 Nov; 64(5):484-91. PubMed ID: 9834040
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome p450 isoforms.
Scollon EJ; Starr JM; Godin SJ; DeVito MJ; Hughes MF
Drug Metab Dispos; 2009 Jan; 37(1):221-8. PubMed ID: 18948380
[TBL] [Abstract][Full Text] [Related]
18. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of o-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1.
Ozawa S; Ohta K; Miyajima A; Kurebayashi H; Sunouchi M; Shimizu M; Murayama N; Matsumoto Y; Fukuoka M; Ohno Y
Xenobiotica; 2000 Oct; 30(10):1005-17. PubMed ID: 11315102
[TBL] [Abstract][Full Text] [Related]
20. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
Kharasch ED; Thummel KE
Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
